Works matching IS 00070920 AND DT 2025 AND VI 132 AND IP 10

Results: 12

Soluble VE-cadherin as a biomarker of response to immunotherapy by anti-PD1 in metastatic melanoma.

Published in:

2025

By:

Broche, Clémentine;
Um, Khémary;
Vilgrain, Isabelle;
Mouret, Stéphane;
Leccia, Marie-Thérèse;
Seigneurin, Arnaud;
Bouillet, Laurence;
Enquebecq, Marie;
Salomon, Aude;
Aspord, Caroline;
Busser, Benoit;
Porret, Pauline;
Belbezier, Aude;
Chaperot, Laurence;
Charles, Julie

Publication type:

Letter

Comprehensive genomic profiling requires a blended ecosystem of learning healthcare and clinical trials.

Published in:

2025

By:

Stenzinger, Albrecht;
Westphalen, C. Benedikt;
Budczies, Jan;
Kazdal, Daniel;
Ploeger, Carolin;
Altbürger, Christian;
Evert, Matthias;
Malek, Nisar;
Schirmacher, Peter;
Klauschen, Frederick

Publication type:

Letter

PD-L1 imaging with [<sup>99m</sup>Tc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer.

Published in:

British Journal of Cancer, 2025, v. 132, n. 10, p. 913, doi. 10.1038/s41416-025-02991-w

By:

Hughes, Daniel Johnathan;
Chand, Gitasha;
Johnson, Jessica;
Tegala, Ronan;
Bailey, Damion;
Adamson, Kathryn;
Edmonds, Scott;
Meszaros, Levente K.;
Moore, Amelia Elizabeth Broomfield;
Manickavasagar, Thubeena;
Ndagire, Susan;
Gennatas, Spyridon;
Georgiou, Alexandros;
Ghosh, Sharmistha;
Josephs, Debra;
Karapanagiotou, Eleni;
McLean, Emma;
Ting, Hong Hoi;
Spicer, James;
Goh, Vicky

Publication type:

Article

First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors.

Published in:

British Journal of Cancer, 2025, v. 132, n. 10, p. 905, doi. 10.1038/s41416-025-02990-x

By:

Day, Daphne;
Ganju, Vinod;
Chung, Ki;
Si, Lu;
Mao, Lili;
Aghmesheh, Morteza;
Hoyer, Robert;
Brewin, Kim;
Zeng, Shuqi;
Zhang, Mingfei;
Lu, Qiaoyang;
Jiang, Chengjun;
Ren, Fang;
Zhu, Yonghong;
Guo, Jun

Publication type:

Article

Rational design of alternative treatment options for radioresistant rectal cancer using patient-derived organoids.

Published in:

British Journal of Cancer, 2025, v. 132, n. 10, p. 973, doi. 10.1038/s41416-025-02989-4

By:

Andel, D.;
Nouwens, A. J.;
Klaassen, S.;
Laoukili, J.;
Viergever, B.;
Verheem, A.;
Intven, M. P. W.;
Zandvliet, M.;
Hagendoorn, J.;
Borel Rinkes, I. H. M.;
Kranenburg, O.

Publication type:

Article

Individualized dynamic risk assessment and treatment selection for multiple myeloma.

Published in:

British Journal of Cancer, 2025, v. 132, n. 10, p. 922, doi. 10.1038/s41416-025-02987-6

By:

Murie, Carl;
Turkarslan, Serdar;
Patel, Anoop P.;
Coffey, David G.;
Becker, Pamela S.;
Baliga, Nitin S.

Publication type:

Article

Artificial intelligence-driven microRNA signature for early detection of gastric cancer: discovery and clinical functional exploration.

Published in:

British Journal of Cancer, 2025, v. 132, n. 10, p. 957, doi. 10.1038/s41416-025-02984-9

By:

Lu, Jiachun;
Chen, Yuqi;
Liu, Xin;
Wang, Jiayu;
He, Yuxin;
Shi, Tongguo;
Chen, Weichang;
Yan, Wenying

Publication type:

Article

Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial.

Published in:

British Journal of Cancer, 2025, v. 132, n. 10, p. 897, doi. 10.1038/s41416-025-02983-w

By:

Yip, Desmond;
Zalcberg, John;
Blay, Jean-Yves;
Eriksson, Mikael;
Espinoza, David;
Price, Timothy;
Marreaud, Sandrine;
Italiano, Antoine;
Steeghs, Neeltje;
Boye, Kjetil;
Underhill, Craig;
Gebski, Val;
Simes, John;
Gelderblom, Hans;
Joensuu, Heikki

Publication type:

Article

Unveiling the origin and functions of diagnostic circulating microRNAs in lung cancer.

Published in:

British Journal of Cancer, 2025, v. 132, n. 10, p. 947, doi. 10.1038/s41416-025-02982-x

By:

Colangelo, Tommaso;
Mazzarelli, Francesco;
Cuttano, Roberto;
Dama, Elisa;
Melocchi, Valentina;
Afanga, Miriam Kuku;
Perrone, Rosa Maria;
Graziano, Paolo;
Bianchi, Fabrizio

Publication type:

Article

Transcriptomic profiling of blood platelets identifies a diagnostic signature for pancreatic cancer.

Published in:

British Journal of Cancer, 2025, v. 132, n. 10, p. 937, doi. 10.1038/s41416-025-02980-z

By:

Ji, Weiping;
Xiong, Yichun;
Yang, Wei;
Shao, Zhuo;
Guo, Xiaoling;
Jin, Gang;
Su, Jianzhong;
Zhou, Meng

Publication type:

Article

A phase 1 study to assess the safety, tolerability and effectiveness of PV-10 (Rose Bengal Sodium) in neuroendocrine tumours metastatic to the liver.

Published in:

British Journal of Cancer, 2025, v. 132, n. 10, p. 888, doi. 10.1038/s41416-025-02976-9

By:

Price, Timothy;
Depauw, Laura;
Cehic, Gabrielle;
Wachter, Eric;
Sebben, Ruben;
Reid, Jessica;
Neuhaus, Susan;
Alawawdeh, Anas;
Kirkwood, Ian D.;
Solanki, Rahul;
McGregor, Mark;
Leopardi, Lisa;
Rodrigues, Dominic;
Maddern, Guy

Publication type:

Article

The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics.

Published in:

British Journal of Cancer, 2025, v. 132, n. 10, p. 869, doi. 10.1038/s41416-025-02969-8

By:

Lin, Hong-Yi;
Jeon, Ah-Jung;
Chen, Kaina;
Lee, Chang Jie Mick;
Wu, Lingyan;
Chong, Shay-Lee;
Anene-Nzelu, Chukwuemeka George;
Foo, Roger Sik-Yin;
Chow, Pierce Kah-Hoe

Publication type:

Article